JAK2 and acute myeloid leukemia: JAK2 KO suppressed the growth of AML cells, measured by an in vitro competition assay (Fig. 1E) and by cumulative cell doubling measurements (Fig. 1F), with a significant increase in Annexin V positive cell death (Fig. 1G).